|
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
|
3 Months Ended | 18 Months Ended | |
|---|---|---|---|
|
Mar. 31, 2012
|
Mar. 31, 2011
|
Mar. 31, 2012
|
|
| REVENUE | |||
| COSTS AND OPERATING EXPENSES | |||
| Research and development | 28,592 | 40,737 | 230,145 |
| Investor relations and marketing | 6,572 | 2,735 | 26,875 |
| Director and management fees | 35,983 | 25,000 | 174,193 |
| Professional fees | 24,187 | 43,213 | 237,412 |
| Travel, office and facilities expenses | 2,058 | 9,766 | 49,966 |
| Costs and operating expenses | 97,392 | 121,451 | 718,591 |
| LOSS FROM OPERATIONS | (97,392) | (121,451) | (718,591) |
| OTHER EXPENSE | |||
| Interest expense | 1,563 | 240 | 2,820 |
| Total other expense | 1,563 | 240 | 2,820 |
| LOSS BEFORE INCOME TAX | (98,955) | (121,691) | (721,411) |
| INCOME TAX PROVISION | |||
| NET LOSS | $ (98,955) | $ (121,691) | $ (721,411) |
| NET LOSS PER COMMON SHARE | |||
| Basic and Diluted | $ 0.00 | $ 0.00 | |
| Weighted Average Shares Outstanding | 85,031,557 | 64,144,833 | |